| 应用 |
Iniparib (BSI-201) is an antineoplastic originally thought to be a poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor. Recent studies indicate Iniparib is not a PARP-1 inhibitor, and its mechanism of action is currently unknown. |
| 产品介绍 |
Iniparib (BSI-201)是一种PARP1抑制剂，对三阴性乳腺癌(TNBC)有效。 |
| 备注 |
BSI-201 (Iniparib, SAR240550) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3. |
| 生化机理 |
BSI-201(Iniparib) is a potent PARP1 inhibitor with strong anti-neoplastic effect. |
| 别名 |
3-硝基-4-碘苯甲酰胺;BSI-201;Iniparib; NSC-746045; IND-71677; BSI 201; BSI201;4-Iodo-3-nitrobenzamide |
